What is the name of the colon capsule endoscopy device and what are its indications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Colon Capsule Endoscopy (CCE)

The colonoscopy camera pill is called Colon Capsule Endoscopy (CCE), with the second-generation device (CCE-2 or PillCam COLON 2) being the current standard, and it should be reserved for patients after incomplete colonoscopy or those with major risks/contraindications to standard colonoscopy—not as a routine substitute for colonoscopy. 1

Device Name and Technology

The device is formally known as Colon Capsule Endoscopy (CCE), with the second-generation capsule (CCE-2 or PillCam COLON 2) representing the current technology. The second-generation device has significantly improved image acquisition compared to the first-generation capsule, with sensitivities of 82-89% for detecting significant polyps (≥6 mm) versus lower rates with CCE-1. 1

FDA-Approved Indications

The U.S. Food and Drug Administration has approved CCE for two specific scenarios 1:

Primary Indications:

  • Incomplete optical colonoscopy - When a standard colonoscopy cannot be completed for technical reasons
  • Major risks for colonoscopy or moderate sedation - Patients with significant contraindications to standard colonoscopy

Additional Regulatory Approval:

Japan's Pharmaceuticals and Medical Devices Agency has approved CCE for diagnosis of colonic disease when colonoscopy is required but difficult to conduct, including patients unwilling or unable to undergo colonoscopy. 1

Clinical Algorithm for Use

When CCE Should Be Considered:

  1. After incomplete colonoscopy - Though referral to an expert center or alternative endoscopic techniques (different endoscopes, device-assisted enteroscopy) should be attempted first, as incomplete colonoscopies are uncommon and can usually be completed with these approaches 1

  2. Patients unwilling to undergo colonoscopy - CCE may improve colorectal cancer screening adherence rates in this select population 1

  3. Contraindications to standard colonoscopy - When sedation or the procedure itself poses major risks 1

When CCE Should NOT Be Used:

  • Routine colorectal cancer screening - The consensus strongly recommends against substituting CCE for colonoscopy routinely (GRADE: Strong recommendation) 1
  • Inflammatory bowel disease assessment - CCE underestimates disease extent and severity in both ulcerative colitis (89% sensitivity, 75% specificity) and Crohn's disease (86% sensitivity, 40% specificity for detecting ulcerations), making colonoscopy the preferred procedure (GRADE: Strong recommendation, 100% agreement) 1

Key Limitations to Discuss with Patients

Critical drawbacks that make colonoscopy superior:

  • Cannot perform therapeutic interventions - Patients with significant polyps detected on CCE will require a subsequent colonoscopy for polypectomy, resulting in two procedures instead of one 1
  • Lower sensitivity and specificity - CCE detects polyps with 68-73% sensitivity versus colonoscopy's higher detection rates 1
  • Technical limitations - Cannot insufflate the colon, aspirate liquids, control capsule transit, or clean the mucosal surface 1
  • Rigorous bowel preparation required - Traditionally requires large-volume PEG-based laxative plus booster (magnesium-based with ascorbic acid), which may be more extensive than standard colonoscopy preparation 1
  • Risk of missed lesions - Patients must be informed about potential for failed procedure, capsule retention, or missed lesions (GRADE: Strong recommendation, 100% agreement) 1

Common Pitfalls to Avoid

Do not use CCE when:

  • Standard colonoscopy is feasible - colonoscopy remains more cost-effective when compliance rates are equal 1
  • Assessing inflammatory bowel disease activity - significant risk of underestimating disease severity 1
  • Patient has known strictures without patency capsule assessment first

The evidence is clear: CCE is a second-line option for the small subset of patients who cannot or will not undergo standard colonoscopy, not a routine alternative to colonoscopy for colorectal cancer screening or surveillance. 1

References

Related Questions

Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
What is the appropriate evaluation and management for a patient with a 0.5 cm round ground‑glass opacity in the right upper lung who has been exposed to chemicals and now presents with a chronic cough?
What is the appropriate lamotrigine maintenance dose for a bipolar patient not taking any enzyme‑inducing medication who is currently on bupropion 150 mg daily, escitalopram 20 mg daily, and clonidine 125 µg daily?
What is the recommended duration of antiviral treatment for influenza A encephalitis?
What are the clinical features of renal cell carcinoma?
What is the recommended management for a patient with total cholesterol 230 mg/dL, triglycerides 84 mg/dL, and LDL cholesterol 152 mg/dL?
What are the proper administration instructions and precautions for doxycycline?
Is it preferable for a transplant candidate to be EBV‑seropositive before transplantation rather than acquire EBV infection from the donor after transplant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.